Kazunori Honda

7PUBLICATIONS
23CO-AUTHORS
Cellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cross-sectional analysisClinical pharmacy and pharmacy practicePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 19, 2026
Response to nivolumab as an immune checkpoint inhibitor rechallenge for esophageal squamous cell carcinoma with PD-L1 amplification: a case report.

|Apr 13, 2026
Development of a visualization tool to estimate out-of-pocket costs for systemic cancer therapy in Japan and claims-based agreement evaluation: the VEST-Ca study.

Kazunori Honda, Kazuhiro Shimomura, Hiroya Taniguchi

|Mar 11, 2026
Socioeconomic and financial factors associated with financial toxicity in Japanese cancer patients: a cross-sectional study.

Kazuki Yokoyama, Kazunori Honda, Kazuko Matsumoto

|Dec 30, 2025
Perceptions and Expectations of Pharmacist Interventions in Adverse Event Management During Drug Therapy for Metastatic Renal Cell Carcinoma: A Cross-Sectional Survey in Japan.

Tetsuya Wako, Go Kimura, Yasuhisa Fujii

|Dec 14, 2024
Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study.

Yukiya Narita, Taro Mizuno, Yasunobu Ishizuka

|May 25, 2024
Financial Toxicity in Japanese Patients with Metastatic Renal Cell Carcinoma: A Cross-Sectional Study.

Go Kimura, Yasuhisa Fujii, Kazunori Honda

Pageof 2

Frequent Collaborators

3 joint publications

Yukiya Narita

3 joint publications

Yasunobu Ishizuka

3 joint publications

Toshiki Masuishi

3 joint publications

Hiroya Taniguchi